Displaying 3141 - 3160 of 4737
Bosley, Inc. Settles FTC Charges That It Illegally Exchanged Competitively Sensitive Business Information With Rival Firm, Hair Club, Inc.
Charlotte Pipe and Foundry Settles Charges That Its 2010 Purchase of Star Pipe's Cast Iron Soil Pipe Business Was Anticompetitive
FTC Seeks Public Comment on Universal Health Services, Inc.'s Application to Divest the Peak Behavioral Health Assets to Strategic Behavioral Health, LLC
FTC Staff: Connecticut Should Consider Expanding Advance Practice Registered Nurses' Role in Patient Care
FTC and Idaho Attorney General Challenge St. Luke's Health System's Acquisition of Saltzer Medical Group as Anticompetitive
FTC Amicus Brief: Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition
FTC Staff Makes Recommendations to Texas Public Utility Commission on Programs to Improve Reliability of Electricity Markets
FTC Approves Final Order Settling Charges That Non-Compete Agreement Harmed Competition in the Market for Bulk Bleach Used to Disinfect Water
FTC and DOJ Extend Public Comment Period for PAE Workshop Through April 5, 2013
Oltrin Solutions, LLC, a company; JCI Jones Chemicals, Inc.
The FTC required bleach producer and seller Oltrin Solutions, LLC to release its competitor, JCI Jones Chemicals, Inc. from an agreement not to sell bleach in North Carolina and South Carolina. This non-compete agreement was part of a 2010 transaction between the two firms that the FTC alleges violated antitrust laws. The FTC’s settlement with Oltrin and JCI will restore competition between these two producers and sellers of bulk bleach, which is primarily used to disinfect water. The FTC contends that the deal between the two firms eliminated substantial competition between Oltrin and JCI in the relevant geographic market; substantially increased the market concentration for bulk bleach sales in the relevant geographic market; and increased Oltrin’s ability to raise bulk bleach prices. The FTC order requires Oltrin to release JCI from the non-compete agreement, transfer a minimum volume of its bulk bleach contracts back to JCI, and provide a short-term backup supply agreement that will facilitate JCI’s re-entry into the bulk bleach market in North Carolina and South Carolina.
In Comments to the Colorado Public Utilities Commission, FTC Staff Expresses Concerns About Proposed Motor Vehicle Transportation Rules
Eight Puerto Rico Kidney Doctors Settle FTC Price-Fixing Charges
Statement of FTC Chairman Jon Leibowitz on the U.S. Supreme Court Ruling in Favor of the Commission in the Phoebe Putney/Palmyra Park Hospital Case
FTC Staff Advises Oklahoma Physician Hospital Organization That it Will Not Recommend Antitrust Challenge to Proposed Formation of Clinically Integrated Multi-provider Network
IDEXX Laboratories, Inc., In the Matter of
The largest U.S. supplier of diagnostic testing products used by small animal veterinarians, IDEXX Laboratories, Inc., agreed to drop its exclusive-dealing arrangements with a top distributor, resolving FTC charges that it was using the exclusive arrangements to stifle competition. IDEXX has agreed to a settlement order that prohibits concurrent exclusive distribution arrangements with the three national distributors of point-of-care (POC) diagnostic testing products. According to the FTC’s complaint, IDEXX has used its dominant market power to reduce competition by threatening to drop the distributors if they carried other companies’ products that compete with IDEXX products.
Displaying 3141 - 3160 of 4737